Biogen (BIIB) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Biogen
Is Biogen a buy right now? The alternative data leans no. This BIIB stock analysis is built on the 25+ alternative data signals AltIndex tracks on Biogen every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 26/100: a Sell. The stock trades at $199.15 with a $29B market cap.
The 90-day pressure points: job postings down 29.7% to 213 open roles, just 53% of employees report a positive business outlook, and web traffic down 10.0% to 141K monthly visits. Stocks scoring below 40 have historically lagged the market.
BIIB’s broader alt-data profile also covers headcount (8K employees, according to LinkedIn), quarterly revenue ($2.5B), X followers (45K), and sentiment (100/100). Every signal links to its own page with full history, the BIIB technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on BIIB is just below.
Biogen AI Stock Analysis
Biogen Inc. is a global biopharmaceutical company headquartered in Cambridge, Massachusetts. The company is known for developing innovative therapies for the treatment of neurological and neurodegenerative diseases. Biogen’s product portfolio primarily includes therapies for multiple sclerosis (MS), spinal muscular atrophy (SMA), and Alzheimer's disease, among others.
Analysis generated June 30, 2026.
Recent Biogen Stock Alerts
|
Biogen | July 8 Maria Elvira Salazar (member of U.S. congress) is selling shares |
|
Biogen | July 3 Gilbert Cisneros (member of U.S. congress) is buying shares |
|
Biogen | June 29 Employee Rating is up by 2.6% over the last month. |
|
Biogen | June 11 Maria Elvira Salazar (member of U.S. congress) is buying shares |
Biogen Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 141K | 10.0% | |
| Job Posts | 213 | 29.7% | |
| LinkedIn Employees | 8K | 2.8% | |
| Employee Recommend | 71 | 14.5% | |
| Business Outlook | 53 | 26.2% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 2 | 88.9% | |
| Stocktwits Mentions | 16 | 300.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 19K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 45K | 0% | |
| Youtube Subscribers | 11K | 1.8% | |
| Facebook Followers | 26K | 0.7% | |
| Facebook Engagement | 468 | 20.5% |
About Biogen (BIIB)
Incorporated in 1978, Massachusetts-based Biogen, Inc. is a biopharmaceutical company, which discovers, develops, and delivers therapies for the treatment of neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, VUMERITY, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis.
| Price | $199.15 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $29B |
| Year Range | $123 – $217 |
| Dividend Yield | 0% |
| PE Ratio | 21.4 |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Biogen News
View more → |
Biogen's Q2 2026 Earnings: What to ExpectJuly 9 - Biztoc.com |
Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right NowJuly 5 - Yahoo Entertainment |
|
 |
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB InvestorsJuly 4 - Biztoc.com |
Block & Leviton LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Biogen, Inc. – BIIBJune 29 - GlobeNewswire |
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIBJune 23 - GlobeNewswire |
|
Biogen Earnings & Financial Performance
View all earnings →Biogen Insider Trading Activity
View all →| Murphy Nicole filed to sell 19,611 shares at $0.0. Feb 12 '26 |
| Singhal Priya filed to sell 8,043 shares at $0.0. Feb 9 '26 |
| Singhal Priya filed to sell 6,271 shares at $0.0. Feb 2 '26 |
| Singhal Priya filed to sell 5,772 shares at $0.0. Sep 2 '25 |
| Izzar Rachid filed to sell 6,330 shares at $0.0. Jul 8 '25 |
Biogen Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Maria Elvira Salazar |
Jul 8, 26 | Sell | $33K+ |
| Gilbert Cisneros |
Jul 3, 26 | Buy | $8K+ |
| Maria Elvira Salazar |
Jun 9, 26 | Buy | $75K+ |
| Maria Elvira Salazar |
Jun 9, 26 | Buy | $8K+ |
| Gilbert Cisneros |
Feb 16, 26 | Buy | $8K+ |
Stocks Similar to Biogen
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
IlluminaILMN |
$190.20 1.8% | $29B | 41 |
 |
Royalty PharmaRPRX |
$56.83 2.0% | $33B | 52 |
 |
West Pharmaceutical ServicesWST |
$353.71 1.1% | $25B | 52 |
 |
IQVIAIQV |
$207.85 0.5% | $35B | 59 |
 |
IncyteINCY |
$116.71 1.5% | $24B | 68 |
Explore Biogen Data
Frequently Asked Questions: Biogen (BIIB)
Biogen has an AltIndex AI Score of 26/100 (Sell). The score reflects negative alternative data signals. All investments carry risk.
26/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Biogen (BIIB) stock is $199.15 with a market cap of $29B.
As of today, Biogen’s PE (Price to Earnings) ratio is 21.4.
View the latest Biogen insider transactions to see recent buying and selling activity by company executives and directors.
Check the Biogen congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The BIIB stock price chart above shows Biogen’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Biogen technical analysis for RSI, moving averages, and more.
See the stocks similar to Biogen section on this page for companies in the same industry ranked by market cap and AI Score.
